Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Handshake HNS Apr 25, 2025 0.01 -6.29   
 Harmony ONE Apr 25, 2025 0.01 +2.71   
 Haven Protocol XHV Apr 25, 2025 0.00 +1.09   
 HazeCoin HAZE Sep 26, 2023 0.00 +0.00   
 Hdac HDAC Apr 25, 2025 0.02 +0.88   
 HeartBout HB Apr 25, 2025 0.00 +0.12   
 Hedera Hashgraph HBAR Apr 25, 2025 0.19 +5.88   
 Hedgecoin HEDG Apr 25, 2025 0.01 +0.02   
 Helium HNT Apr 25, 2025 4.16 +18.47   
 HEROcoin PLAY Apr 25, 2025 0.00 +0.01   
 HEX HEX Apr 25, 2025 0.00 -9.89   
 High Performance Blockchain HPB Apr 25, 2025 0.00 -10.03   
 Hive HVN Apr 25, 2025 0.00 +0.69   
 Hive HIVE Apr 25, 2025 0.25 +2.74   
 Holo HOT Apr 25, 2025 0.00 +4.20   
 Homeros HMR Apr 25, 2025 0.03 +0.01   
 Humaniq HMQ Apr 25, 2025 0.00 +0.61   
 Huobi Token HT Apr 25, 2025 0.39 +20.17   
 Hxro HXRO Apr 25, 2025 0.06 +0.01   
 HYCON HYC Apr 25, 2025 0.00 0.00   
 HyperCash HC Apr 25, 2025 0.02 +0.94   
 Hyperion HYN Apr 25, 2025 0.00 +0.01   
 Hyperliquid HYPE Apr 25, 2025 18.76 +3.59   
 I-House Token IHT Apr 25, 2025 0.00 +0.04   
 ICON Project ICX Apr 25, 2025 0.11 +4.20   
 IDEX IDEX Apr 25, 2025 0.03 +5.60   
 iEx.ec RLC Apr 25, 2025 1.22 +2.37   
 Ignis IGNIS Apr 25, 2025 0.00 +18.75   
 Illuvium ILV Apr 25, 2025 14.95 +3.13   
 Impact IMX Apr 25, 2025 0.59 +2.17   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Data:


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.